Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer Cells
Makoto Isono(Heinrich Heine University Düsseldorf), Tomohiko Asano(National Defense Medical College)
Cited by 11
Related Papers
Checkpoint kinase inhibitor AZD7762 strongly sensitises urothelial carcinoma cells to gemcitabine
|Journal of Experimental & Clinical Cancer Research|2017|81
Increased expression of α-actinin-4 is associated with unfavorable pathological features and invasiveness of bladder cancer
|Oncology Reports|2013|31
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells
|Anticancer Research|2018|24
Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells
|Scientific Reports|2021|22